Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 24

Article ID: 714844

AASLD Foundation Invests $3.42 Million in Liver Disease Research and Career Development

American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases Foundation, the largest private supporter of liver disease research and training in the United States, today announced its investment of $3.42 million in Research and Career Development Awards granted to 29 researchers and clinicians to conduct innovative liver disease research and seek advanced hepatology training.

Released:
24-Jun-2019 4:30 PM EDT
Open in New Tab
Comment

Feature

Channels:

Budgets and Funding, Liver Disease,

Languages:

English

  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703285

Weight-Loss Surgery Effectively Reduces Weight and Lowers Risk of Post- Liver Transplant Complications in Obese Patients

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that weight-loss surgery prior to liver transplantation is superior to medical weight loss approaches at achieving sustained weight loss, as well as significantly lowering risk of metabolic complications after transplant.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703286

Clinically Significant Liver Toxicity Related to Anti-Cancer Drugs is Rare but Often Leads to Discontinuation of Treatment

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that patients treated with immune checkpoint inhibitors rarely develop severe liver toxicity, but the majority of those who do permanently stop this cancer treatment. None of the patients developed liver failure as a result of this treatment.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703287

Liver Cancer Combined with Other Liver Diseases Driving Higher Death Rate and Health Care Costs for U.S. Seniors

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hospitalizations and death are increasing among Medicare recipients with hepatocellular carcinoma, mainly due to co-existing alcoholic liver disease, hepatitis C virus infection (commonly called HCV) and nonalcoholic fatty liver disease (commonly called NAFLD).

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703288

People with Hepatitis C Who Actively Inject Illegal Drugs Have High Rates of Hepatitis C Treatment Adherence and Cure

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that people who inject drugs who are infected with the hepatitis C virus have high rates of hepatitis C treatment adherence (completion of their treatment), and sustained virologic response. Based on these findings, researchers conclude these patients should be included in HCV treatment programs.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703289

African-Americans Face Significant Delays in Liver Transplantation Despite High Priority Scores

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that African-American patients on waitlists for liver transplantation, despite severe disease and high scores for prioritization, persistently face significant disparities and delays in referral.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703290

Combined Glecaprevir and Pibrentasvir Found Highly Effective in Chronic Hepatitis C Patients Who Have Failed Other Therapies

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found the combination of glecaprevir and pibrentasvir is highly effective and well tolerated in patients with chronic hepatitis C virus (commonly called HCV) genotype-1 infections who have prior treatment experience with sofosbuvir/NS5A inhibitor.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703292

Universal Hepatitis C Screening of Pregnant Women More Cost-Effective Than Risk-Based Approach

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by The American Association for the Study of Liver Diseases – found that universal screening of pregnant women at risk for hepatitis C virus (commonly called HCV) infection is a more efficient and cost-effective diagnostic approach than risk-based screening.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703293

Nonalcoholic Fatty Liver Disease Patients Have Higher Rates of All Non-Liver-Related Cancers

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that rates of malignancy occurring outside of the liver were higher in adults with nonalcoholic fatty liver disease than among adults across most types of cancers.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703294

Normothermic Machine Perfusion Can Salvage Fatty Livers for Transplantation

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that using normothermic machine perfusion to preserve steatotic livers leads to altered lipid structure and metabolism and may result in more successful transplantation of these organs.

Released:
2-Nov-2018 2:30 PM EDT
Open in New Tab
Comment

Showing results

110 of 24

Chat now!